Sickle-cell disease.
Rees DC, Williams TN, Gladwin MT.
Lancet. 2010 Dec 11;376(9757):2018-31. doi: 10.1016/S0140-6736(10)61029-X. Epub 2010 Dec 3.
Advances in the diagnosis and treatment of sickle cell disease.
Brandow AM, Liem RI.
J Hematol Oncol. 2022 Mar 3;15(1):20. doi: 10.1186/s13045-022-01237-z.
Understanding Sickle cell disease: Causes, symptoms, and treatment options.
Elendu C, Amaechi DC, Alakwe-Ojimba CE, Elendu TC, Elendu RC, Ayabazu CP, Aina TO, Aborisade O, Adenikinju JS.
Medicine (Baltimore). 2023 Sep 22;102(38):e35237. doi: 10.1097/MD.0000000000035237.
Sickle cell disease: A primary care update.
Onimoe G, Rotz S.
Cleve Clin J Med. 2020 Jan;87(1):19-27. doi: 10.3949/ccjm.87a.18051. Epub 2020 Jan 2.
Sickle Cell Disease: Monitoring, Current Treatment, and Therapeutics Under Development.
Hoppe C, Neumayr L.
Hematol Oncol Clin North Am. 2019 Jun;33(3):355-371. doi: 10.1016/j.hoc.2019.01.014. Epub 2019 Mar 28.
Treatment Options for Sickle Cell Disease.
Meier ER.
Pediatr Clin North Am. 2018 Jun;65(3):427-443. doi: 10.1016/j.pcl.2018.01.005.
Neurologic Complications of Sickle Cell Disease.
Farooq S, Testai FD.
Curr Neurol Neurosci Rep. 2019 Feb 28;19(4):17. doi: 10.1007/s11910-019-0932-0.
Sickle cell disease.
[No authors listed]
Nat Rev Dis Primers. 2018 Mar 15;4:18011. doi: 10.1038/nrdp.2018.11.
Sickle cell disease: a year in review.
The Lancet Haematology.
Lancet Haematol. 2022 Jun;9(6):e385. doi: 10.1016/S2352-3026(22)00144-2.
Sickle cell anemia, the first molecular disease: overview of molecular etiology, pathophysiology, and therapeutic approaches.
Steinberg MH.
ScientificWorldJournal. 2008 Dec 25;8:1295-324. doi: 10.1100/tsw.2008.157.
